Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 226 of the 229 references it cites were found in a registry or an index.

Cholangiokines: undervalued modulators in the hepatic microenvironment

Open access
Cai, Xiurong, Tacke, Frank, Guillot, Adrien, Liu, Hanyang · 2023 · Frontiers in Immunology

Abstract

The biliary epithelial cells, also known as cholangiocytes, line the intra- and extrahepatic bile ducts, forming a barrier between intra- and extra-ductal environments. Cholangiocytes are mostly known to modulate bile composition and transportation. In hepatobiliary diseases, bile duct injury leads to drastic alterations in cholangiocyte phenotypes and their release of soluble mediators, which can vary depending on the original insult and cellular states (quiescence, senescence, or proliferation). The cholangiocyte-secreted cytokines (also termed cholangiokines) drive ductular cell proliferation, portal inflammation and fibrosis, and carcinogenesis. Hence, despite the previous consensus that cholangiocytes are bystanders in liver diseases, their diverse secretome plays critical roles in modulating the intrahepatic microenvironment. This review summarizes recent insights into the cholangiokines under both physiological and pathological conditions, especially as they occur during liver injury-regeneration, inflammation, fibrosis and malignant transformation processes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2023.1192840

Cites

226 of 226 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Ductular reaction and cholangiokine secretion Cholangiocytes stand as a crucial component in the hepatic portal areas, maintaining liver homeostasis. Cholangiocellular phenotypes can be altered by cholestasis, exogenous stimulus, and inflammatory factors. Besides evidence and debates on cholangiocyte stemization and hepatocyte-cholangiocyte trans-differentiation, activated cholangiocytes drive the DR by producing variable cytokines and chemokines, termed cholangiokines. Furthermore, cholangiokines are responsible for autocrine and paracrine effects in the portal microenvironment. CIC, circulating immune cell; DAMPs, damage-associated molecular patterns; HC, hepatic cell; HSC, hepatic stellate cell; KC, Kupffer cell; PAMPs, pathogen-associated molecular patterns.
Figure 1 Ductular reaction and cholangiokine secretion Cholangiocytes stand as a crucial component in the hepatic portal areas, maintaining liver homeostasis. Cholangiocellular phenotypes can be altered by cholestasis, exogenous stimulus, and inflammatory factors. Besides evidence and debates on cholangiocyte stemization and hepatocyte-cholangiocyte trans-differentiation, activated cholangiocytes drive the DR by producing variable cytokines and chemokines, termed cholangiokines. Furthermore, cholangiokines are responsible for autocrine and paracrine effects in the portal microenvironment. CIC, circulating immune cell; DAMPs, damage-associated molecular patterns; HC, hepatic cell; HSC, hepatic stellate cell; KC, Kupffer cell; PAMPs, pathogen-associated molecular patterns.CC BY · PubMed Central
Figure 2 Phenotype-depending secretion and functionality of cholangiokines. Cholangiocytes convert to a major source of functional cytokines in addition to hepatocytes and immune cells. Cholangiokines exert perpetual influences on the hepatic environment. Quiescence-associated cholangiokines maintain liver homeostasis, whereas cholangiokines released by cholangiocytes at their activated statuses (e.g., proliferation, senescence and injury) mediate hepatocellular proliferation, fibrogenesis, DR and inflammation, which eventually cause hepatic carcinogenesis. IL, interleukin; CCL, chemokine (C-C motif) ligand; EGF, epidermal growth factor; IgA, immunoglobulin A; TGF-β, transforming growth factor-β; IGF-1, insulin-like growth factor 1; IFN-γ, Interferon gamma; TFF, trefoil factor; CXCL, chemokine (C-X-C motif) ligand; AREG, amphiregulin; HB-EGF, heparin-binding-EGF; FGF-19, fibroblast growth factor-19; TNF-α, tumor necrosis factor-α; VEGF, vascular endothelial growth factor, PDGF-BB, platelet-derived growth factor; CTGF, connective tissue growth factor; NGF, nerve growth factor; MIP-3α, macrophage inflammatory protein-3α; MMP, matrix metallopeptidase.
Figure 2 Phenotype-depending secretion and functionality of cholangiokines. Cholangiocytes convert to a major source of functional cytokines in addition to hepatocytes and immune cells. Cholangiokines exert perpetual influences on the hepatic environment. Quiescence-associated cholangiokines maintain liver homeostasis, whereas cholangiokines released by cholangiocytes at their activated statuses (e.g., proliferation, senescence and injury) mediate hepatocellular proliferation, fibrogenesis, DR and inflammation, which eventually cause hepatic carcinogenesis. IL, interleukin; CCL, chemokine (C-C motif) ligand; EGF, epidermal growth factor; IgA, immunoglobulin A; TGF-β, transforming growth factor-β; IGF-1, insulin-like growth factor 1; IFN-γ, Interferon gamma; TFF, trefoil factor; CXCL, chemokine (C-X-C motif) ligand; AREG, amphiregulin; HB-EGF, heparin-binding-EGF; FGF-19, fibroblast growth factor-19; TNF-α, tumor necrosis factor-α; VEGF, vascular endothelial growth factor, PDGF-BB, platelet-derived growth factor; CTGF, connective tissue growth factor; NGF, nerve growth factor; MIP-3α, macrophage inflammatory protein-3α; MMP, matrix metallopeptidase.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 229 references

Cited by

See all 45

Metadata

Authors
Cai, X., Tacke, F., Guillot, A., & Liu, H.
Affiliations
  • Charité – Universitätsmedizin Berlin (DE)
  • Stiftung Charité (DE)
  • Changzhou No.2 People's Hospital (CN)
Corresponding author
  • Guillot, Adrien
  • Liu, Hanyang
Venue
Frontiers in Immunology
Published
2023-05-16
Volume
14
Pages
1192840-1192840
ISSN
1664-3224 (ISSN-L)
OpenAlex
W4376954999
Cited by
40
References
229
Citations by year
2026: 9 · 2025: 21 · 2024: 8 · 2023: 2
FWCI
1.73
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Deutsche Forschungsgemeinschaft (DFG SFB/TRR 296, CRC1382, 403224013)
  • Deutsche Gesellschaft für Erziehungswissenschaft (BMBF DEEP-HCC consortium)
  • Changzhou Science and Technology Bureau (CJ20220142)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
Keywords
cholangiocytes, cytokines, bile duct injury, liver fibrosis, ductular reaction, liver regeneration, liver inflammation, hepatocarcinogenesis, cellular senescence, biliary tract
MeSH terms
Bile Ducts, Epithelial Cells, Fibrosis, Humans, Inflammation, Liver

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cholangiokines: undervalued modulators in the hepatic microenvironment. https://app.cochat.ai/papers/10.3389/fimmu.2023.1192840
The paper
Cai, X., Tacke, F., Guillot, A., & Liu, H. (2023). Cholangiokines: undervalued modulators in the hepatic microenvironment. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1192840

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.